USD 3.12
(-11.36%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 16.85 Million USD | -57.28% |
2022 | 39.46 Million USD | 131.38% |
2021 | 17.05 Million USD | 127.86% |
2020 | -61.22 Million USD | -193.0% |
2019 | -20.89 Million USD | -2766.26% |
2018 | -729 Thousand USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q3 | 12.23 Million USD | -2.8% |
2024 Q1 | 10.27 Million USD | 181.97% |
2024 Q2 | 12.58 Million USD | 22.48% |
2023 Q1 | 9.08 Million USD | -4.89% |
2023 FY | 16.85 Million USD | -57.28% |
2023 Q3 | 9.38 Million USD | -14.1% |
2023 Q2 | 10.92 Million USD | 20.17% |
2023 Q4 | -12.53 Million USD | -233.62% |
2022 Q1 | 8.34 Million USD | 10.64% |
2022 Q2 | 10.57 Million USD | 26.73% |
2022 FY | 39.46 Million USD | 131.38% |
2022 Q4 | 9.55 Million USD | -13.04% |
2022 Q3 | 10.98 Million USD | 3.94% |
2021 Q2 | 8.22 Million USD | 28.12% |
2021 FY | 17.05 Million USD | 127.86% |
2021 Q4 | 7.54 Million USD | 247.21% |
2021 Q3 | -5.12 Million USD | -162.31% |
2021 Q1 | 6.41 Million USD | -26.24% |
2020 Q1 | -836 Thousand USD | 94.07% |
2020 Q4 | 8.69 Million USD | 112.56% |
2020 Q3 | -69.25 Million USD | -42070.3% |
2020 Q2 | 165 Thousand USD | 119.74% |
2020 FY | -61.22 Million USD | -193.0% |
2019 FY | -20.89 Million USD | -2766.26% |
2019 Q4 | -14.1 Million USD | 0.0% |
2018 FY | -729 Thousand USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Abbott Laboratories | 22.13 Billion USD | 99.924% |
Allurion Technologies Inc. | 41.49 Million USD | 59.38% |
Artivion, Inc. | 229.17 Million USD | 92.645% |
Avanos Medical, Inc. | 379.7 Million USD | 95.561% |
Butterfly Network, Inc. | 16.85 Million USD | 0.0% |
Bio-Rad Laboratories, Inc. | 1.43 Billion USD | 98.822% |
Boston Scientific Corporation | 9.89 Billion USD | 99.83% |
Perspective Therapeutics, Inc. | 1.63 Million USD | -931.579% |
CONMED Corporation | 643.06 Million USD | 97.379% |
Edwards Lifesciences Corporation | 4.62 Billion USD | 99.636% |
Paragon 28, Inc. | 172.79 Million USD | 90.245% |
Glaukos Corporation | 239.13 Million USD | 92.951% |
Globus Medical, Inc. | 1.02 Billion USD | 98.348% |
Inspire Medical Systems, Inc. | 528.22 Million USD | 96.809% |
Integer Holdings Corporation | 418.28 Million USD | 95.97% |
Medtronic plc | 19.45 Billion USD | 99.913% |
Nevro Corp. | 290.06 Million USD | 94.189% |
Owlet, Inc. | 22.58 Million USD | 25.373% |
Penumbra, Inc. | 682.64 Million USD | 97.531% |
Vicarious Surgical Inc. | -1.85 Million USD | 1009.169% |
Smith & Nephew plc | 3.7 Billion USD | 99.545% |
Sonendo, Inc. | 10.72 Million USD | -57.209% |
STERIS plc | 2.23 Billion USD | 99.245% |
Stryker Corporation | 13.05 Billion USD | 99.871% |
Vapotherm, Inc. | 28.28 Million USD | 40.402% |
Zimmer Biomet Holdings, Inc. | 5.31 Billion USD | 99.683% |